A Response to: Letter to the Editor Regarding "Gabapentin has Longer-Term Efficacy for the Treatment of Chronic Pelvic Pain in Women: A Systematic Review and Pilot Meta-analysis"

Pain Ther. 2022 Mar;11(1):321-325. doi: 10.1007/s40122-021-00352-y. Epub 2022 Jan 19.

Yi-Feng Ren^#¹, Xiu-Mei Fan^#¹, Xi Fu¹, Hao Wu¹, Xin Ye¹, Yi-Fang Jiang^{2

3}, Feng-Ming You^{4

5}

¹ Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan Province, China.
² Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan Province, China. jyftcm@163.com.
³ TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan Province, China. jyftcm@163.com.
⁴ Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan Province, China. yfmdoc@163.com.
⁵ TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, Sichuan Province, China. yfmdoc@163.com.

^# Contributed equally.

No abstract available

Keywords: Chronic pelvic pain; Gabapentin; Longer-term benefits.

Publication types